Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously ...

SEATTLE--(BUSINESS WIRE)--Receptor Life Sciences (RLS) today announced the acceptance of two posters for presentation at the Respiratory Drug Delivery (RDD 2021) conference.The posters report ...

NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the ...

atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at the 2023 SOBP Annual Meeting atai Life Sciences Fri, Apr 28, 2023, 6:59 AM 7 min read ...

Life Science students display research papers at the 2022 CURA poster presentation Over seventy Life Science students displayed their research through posters hung in the BYU Conference Center on ...

Graduate and Undergraduate students are welcome. Your poster does not have to be ready in order to submit this application, however, your poster will need to be printed before the day of the event ...

Please carefully review the requirements to create a printed poster presentation. Your poster serves as a "visual aid" to your 1-2 minute verbal explanation of your research to audience members. It is ...

Poster presentations may not seem as prestigious as oral presentations, but they are a great opportunity to interact with other scientists in your field in a reasonably structured way. You must ...

Poster Presentation Poster applications for the 2025 Office of Interdisciplinary Graduate Program's (OIGP) Spring Reception are now closed. Our reception will take place in-person this year on May 7th ...

Poster presentations are a staple of academic conferences. They’re a valuable way to share research visually, and it pays to know how to design one well . The good news is, we seem to be living in a ...

Greenwich LifeSciences skyrocketed as much as 2,941% on Wednesday following encouraging phase 2b data for its breast cancer immunotherapy treatment, GP2. A poster presentation for GP2 at the San ...

‒ Poster for GP2 Phase IIb clinical trial final efficacy analysis was presented during the 2020 San Antonio Breast Cancer Symposium (SABCS) today ‒ Phase IIb clinical trial was a prospective ...